WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company

Aurobindo Pharma secures FTC approval for a $250 million acquisition of Lannett Company, enhancing its U.S. manufacturing capabilities.

Raccontata daeconomictimes.indiatimes.comthehindubusinessline.comthehindu.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
thehindu.comStai leggendo10 g fa

Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company

Aurobindo Pharma secures FTC approval for a $250 million acquisition of Lannett Company, enhancing its U.S. manufacturing capabilities.

originale
economictimes.indiatimes.com10 g fa

Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett Company

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic move, expected to conclude by June 2026, will bolster Aurobindo's complex…

Leggi questa versione →

Timeline cronologica

  1. lunedì 22 giugno 2026·economictimes.indiatimes.com

    Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett Company

    Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic move, expected to conclude by June…

  2. lunedì 22 giugno 2026·thehindubusinessline.com

    Aurobindo Pharma gets US FTC’s nod to acquire Lannett Company

    Aurobindo Pharma’s US subsidiary receives US FTC approval to acquire Lannett Company for $250 million, strengthening its position in non-opioid controlled substances and domestic…

originale
thehindubusinessline.com10 g fa

Aurobindo Pharma gets US FTC’s nod to acquire Lannett Company

Aurobindo Pharma’s US subsidiary receives US FTC approval to acquire Lannett Company for $250 million, strengthening its position in non-opioid controlled substances and domestic manufacturing.

Leggi questa versione → originale
  • lunedì 22 giugno 2026·thehindu.com

    Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company

    Aurobindo Pharma secures FTC approval for a $250 million acquisition of Lannett Company, enhancing its U.S. manufacturing capabilities.